Chemomab Therapeutics Ltd.
- Last sale
- Nov 12, 2026 · +1.45%
- Market cap
- $10.07M
- 7.19M shares
- Filings
- 368
—
—
—FY 2025N/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
FY 2025−53.8% FY25 yoy
FY 2025+24.6% FY25 yoy
- $10.07M
- —
- —
- 0.8×
- -110.57%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Cost of Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2,326,000 | reported | |
| FY 2024 | 2024-12-31 | $2,465,000 | reported | |
| FY 2023 | 2023-12-31 | $4,393,000 | reported | |
| FY 2022 | 2022-12-31 | $5,142,000 | reported | |
| FY 2021 | 2021-12-31 | $3,310,000 | reported |
Pharmaceutical preparations
Chemomab Therapeutics Ltd. is the 416th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
VBIOValion Bio, Inc.———$11.3MACUTAccustem Sciences Inc.———$11.3MHINDVyome Holdings, Inc$319.7K96.0%3,209.7%$11.1MBFRGBullFrog AI Holdings, Inc.$116.7K—5,569.6%$10.5M
CMMBChemomab Therapeutics Ltd. (this company)———$10.1M
DAREDare Bioscience, Inc.———$9.9MGDTCCytoMed Therapeutics Ltd$252.3K395.9%1,227.1%$9.8MPHIOPhio Pharmaceuticals Corp.———$9.6MINBPIntegrated Biopharma Inc$43.9M19.3%6.5%$9.1MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Chemomab Therapeutics Ltd. · CIK 1534248 · Engraved from SEC EDGAR